Alternative Names: Palmitoyl Tripeptide-1, Palmitoyl Oligopeptide Pal-GHK Studies and Research Data Antioxidative Pathways and Free Radical Modulation Experimental findings suggest that Pal-GHK may interact with genes associated with antioxidant activity
and his Make America Healthy Again (MAHA) movement have promoted as cure-alls for everything from injuries to aging
Pen Dosage Chart Dosage & Protocols Variations Standard Research Protocol Dose: 0.5 1 mg (variant 5 + 5 mg pen = 1020 clicks / variant 10 + 10 mg pen = 510 clicks) Duration: 4 6 weeks Frequency: 1 daily Cycle Interval: 4 week rest Goal / Description: Basic tissue recovery support model Enhanced Regeneration Protocol Dose: 1 1.5 mg (variant 5 + 5 mg pen = 2030 clicks / variant 10 + 10 mg pen = 1015 clicks) Duration: 8 12 weeks Frequency: Every other day Cycle Interval: 4 week rest Goal / Description: Designed for extended regenerative studies, emphasizing vascular and muscular adaptation Post-Load Model Dose: 2 mg (variant 5 + 5 mg pen = 40 clicks / variant 10 + 10 mg pen = 20 clicks) Duration: 2 4 weeks Frequency: 1 daily Cycle Interval: 2 week rest Goal / Description: Applied in post-strain or high-load experimental recovery Biohacker Protocol Dose: 0.5 mg (variant 5 + 5 mg pen = 10 clicks / variant 10 + 10 mg pen = 5 clicks) Duration: Continuous Frequency: 5 weekly Cycle Interval: 2 week rest Goal / Description: Experimental long-term maintenance design emphasizing consistent angiogenic response Possible Side Effects The BPC-157 & TB-500 blend, as research peptides involved in regeneration, may elicit side effects in experimental models, mainly at injection sites or systemically
In each of these, mast cell activation appears to play a role in symptom severity, barrier dysfunction, and disease progression
WADA status BPC-157 BPC-157 has no approval from any governmental regulatory health authority for human therapeutic use, and as such falls under WADA category S0 (Non-Approved Substances), prohibited at all times (ref
